Hemostemix Stock Market Value
| HEM Stock | CAD 0.08 0.01 5.88% |
| Symbol | Hemostemix |
Hemostemix Price To Book Ratio
Hemostemix 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Hemostemix's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Hemostemix.
| 12/05/2022 |
| 11/24/2024 |
If you would invest 0.00 in Hemostemix on December 5, 2022 and sell it all today you would earn a total of 0.00 from holding Hemostemix or generate 0.0% return on investment in Hemostemix over 720 days. Hemostemix is related to or competes with VentriPoint Diagnostics. Hemostemix Inc., a clinical-stage biotechnology company, develops, manufactures, and commercializes blood-derived cell t... More
Hemostemix Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Hemostemix's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Hemostemix upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 13.29 | |||
| Information Ratio | 0.1199 | |||
| Maximum Drawdown | 57.27 | |||
| Value At Risk | (18.18) | |||
| Potential Upside | 22.22 |
Hemostemix Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hemostemix's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Hemostemix's standard deviation. In reality, there are many statistical measures that can use Hemostemix historical prices to predict the future Hemostemix's volatility.| Risk Adjusted Performance | 0.1098 | |||
| Jensen Alpha | 1.6 | |||
| Total Risk Alpha | (0.32) | |||
| Sortino Ratio | 0.1059 | |||
| Treynor Ratio | (2.75) |
Hemostemix Backtested Returns
Hemostemix is out of control given 3 months investment horizon. Hemostemix holds Efficiency (Sharpe) Ratio of 0.11, which attests that the entity had a 0.11% return per unit of risk over the last 3 months. We were able to interpolate thirty different technical indicators, which can help you to evaluate if expected returns of 1.18% are justified by taking the suggested risk. Use Hemostemix Risk Adjusted Performance of 0.1098, downside deviation of 13.29, and Market Risk Adjusted Performance of (2.74) to evaluate company specific risk that cannot be diversified away. Hemostemix holds a performance score of 8 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of -0.56, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Hemostemix are expected to decrease at a much lower rate. During the bear market, Hemostemix is likely to outperform the market. Use Hemostemix sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to analyze future returns on Hemostemix.
Auto-correlation | 0.04 |
Virtually no predictability
Hemostemix has virtually no predictability. Overlapping area represents the amount of predictability between Hemostemix time series from 5th of December 2022 to 30th of November 2023 and 30th of November 2023 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Hemostemix price movement. The serial correlation of 0.04 indicates that only as little as 4.0% of current Hemostemix price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.04 | |
| Spearman Rank Test | 0.09 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Hemostemix lagged returns against current returns
Autocorrelation, which is Hemostemix stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Hemostemix's stock expected returns. We can calculate the autocorrelation of Hemostemix returns to help us make a trade decision. For example, suppose you find that Hemostemix has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Hemostemix regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Hemostemix stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Hemostemix stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Hemostemix stock over time.
Current vs Lagged Prices |
| Timeline |
Hemostemix Lagged Returns
When evaluating Hemostemix's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Hemostemix stock have on its future price. Hemostemix autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Hemostemix autocorrelation shows the relationship between Hemostemix stock current value and its past values and can show if there is a momentum factor associated with investing in Hemostemix.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hemostemix Stock Analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.